These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30260985)

  • 1. Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.
    El-Abhar H; Abd El Fattah MA; Wadie W; El-Tanbouly DM
    PLoS One; 2018; 13(9):e0203837. PubMed ID: 30260985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors.
    Shalaby HN; El-Tanbouly DM; Zaki HF
    Food Chem Toxicol; 2018 Aug; 118():227-234. PubMed ID: 29753867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.
    Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG
    Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: Cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway.
    Abdel Rasheed NO; Ibrahim WW
    Life Sci; 2022 May; 297():120480. PubMed ID: 35278421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats.
    Khan A; Jamwal S; Bijjem KR; Prakash A; Kumar P
    Neuroscience; 2015 Feb; 287():66-77. PubMed ID: 25536048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
    Hedya SA; Safar MM; Bahgat AK
    Mol Neurobiol; 2018 Sep; 55(9):7579-7587. PubMed ID: 29429051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 directly protects cortical neurons by activating PI3K/AKT/NF-κB/CREB pathways.
    Zhou J; Ping FF; Lv WT; Feng JY; Shang J
    Cytokine; 2014 Sep; 69(1):29-38. PubMed ID: 25022959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of TrkB agonist in neuronal survival by promoting CREB/BDNF and PI3K/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death.
    Ahmed S; Kwatra M; Gawali B; Panda SR; Naidu VGM
    Apoptosis; 2021 Feb; 26(1-2):52-70. PubMed ID: 33226552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin Prevents SH-SY5Y Cells from Rotenone-Induced Apoptosis via the PI3K/Akt/GSK-3β/CREB Signaling Pathway.
    Wu X; Liang Y; Jing X; Lin D; Chen Y; Zhou T; Peng S; Zheng D; Zeng Z; Lei M; Huang K; Tao E
    Neurochem Res; 2018 Apr; 43(4):886-893. PubMed ID: 29435803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M-dependent Mcl-1 induction mediated by JAK1/2-STAT1/3 and CREB contributes to bioenergetic improvements and protective effects against mitochondrial dysfunction in cortical neurons.
    Chang SH; Hwang CS; Yin JH; Chen SD; Yang DI
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2306-25. PubMed ID: 25986861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase.
    Nandan D; Camargo de Oliveira C; Moeenrezakhanlou A; Lopez M; Silverman JM; Subek J; Reiner NE
    J Immunol; 2012 Jan; 188(1):367-78. PubMed ID: 22140263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of a green tea polyphenol, epigallocatechin-3-gallate, against sevoflurane-induced neuronal apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/Akt/mTOR signalling pathways in neonatal mice.
    Ding ML; Ma H; Man YG; Lv HY
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1396-1405. PubMed ID: 28679060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway.
    El-Shamarka ME; El-Sahar AE; Saad MA; Assaf N; Sayed RH
    Life Sci; 2022 Jul; 300():120569. PubMed ID: 35472453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.
    Hayashi H; Sudo T
    Thromb Haemost; 2009 Aug; 102(2):327-35. PubMed ID: 19652884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.
    Sayed NH; Fathy N; Kortam MA; Rabie MA; Mohamed AF; Kamel AS
    Neurotherapeutics; 2020 Jan; 17(1):252-268. PubMed ID: 31728850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation.
    Ohashi E; Kohno K; Arai N; Harashima A; Ariyasu T; Ushio S
    Biol Pharm Bull; 2019; 42(6):968-976. PubMed ID: 31155593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta.
    Gross ER; Hsu AK; Gross GJ
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H827-34. PubMed ID: 16517948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting.
    Noureldeen ME; Shahin NN; Amin HAA; El-Sawalhi MM; Ghaiad HR
    Mol Med; 2024 Sep; 30(1):158. PubMed ID: 39327568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against potassium deprivation-induced apoptosis involves the Akt pathway and inhibition of cell cycle reentry.
    Yeste-Velasco M; Folch J; Casadesús G; Smith MA; Pallàs M; Camins A
    Neuroscience; 2009 Mar; 159(3):1135-47. PubMed ID: 19356694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.